When it comes to life science investors looking at deals in the booming field of health IT, some are sticking with the old line, “It’s not you; it’s me.”
Certainly many life science investors are making bets in health IT, but many others have shied away, even as the market matures and exits pick up. According to panelists at Cleveland Clinic’s Medical Innovation Summit, the hesitancy is not necessarily because investors aren’t convinced of the value of these companies.
Image Courtesy of photostock / FreeDigitalPhotos.net
